From: Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
Patient
C1D1
C1D15
C3D1
#1
59
20
8
#2
7
4
#3
77
24
#4
9
2
3
#5
1
#6
0
#7
2107
25
#8
10
12
#9
#10
19
16
#11
60
34
6
#12
11
#13
#14
175
17
#15
14
22
18
#16
#17
122